BreachRx is an intelligent incident response platform that generates tailored response plans and provides targeted guidance to stakeholders.
BreachRx has raised $15.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
BreachRx's investors include Ballistic Ventures, Alchemist Accelerator, SYN Ventures, Overline, OODA.
BreachRx is headquartered in Ashburn, United States.
BreachRx is an intelligent incident response platform that generates tailored response plans and provides targeted guidance to stakeholders.
BreachRx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BreachRx — Funding & Investors." VCBacked, May 19, 2025, https://www.vcbacked.co/company/breachrx. Accessed October 16, 2026.
VCBacked. (2025). BreachRx — Funding & Investors. Retrieved October 16, 2026, from https://www.vcbacked.co/company/breachrx
{{cite web |title=BreachRx — Funding & Investors |url=https://www.vcbacked.co/company/breachrx |website=VCBacked |access-date=October 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated